Sign in
4

Changes in Ownership

NEKTAR THERAPEUTICS Filed Acc 0001209191-21-065223

SVP & Chief Accounting Officer sold 6,741 shares at $13.16 ($88,712)

  • SVP & Chief Accounting Officer acquired 14,900 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Thomsen Jillian B. · SVP & Chief Accounting Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2021-11-15 Grant or award : show line 1 in the form +14,900 152,722 D
2021-11-16 Sale : show line 2 in the form −6,741 $13.16 $88,712 145,981 D
Open-market sales · 6,741 sh · avg $13.16 · $88,712
Loading xslF345X03/doc4.xml…